Henry Szczepanski
Syngenta
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Henry Szczepanski.
Pest Management Science | 2011
Michel Muehlebach; Fredrik Cederbaum; Derek Cornes; Adrian Friedmann; Jutta Glock; Gavin John Hall; Adriano Indolese; Daniel P. Kloer; Gael Le Goupil; Thomas Maetzke; Hans Meier; Rudolf Schneider; André Stoller; Henry Szczepanski; Sebastian Wendeborn; Hansjuerg Widmer
BACKGROUND Pinoxaden is a new cereal herbicide that provides outstanding levels of post-emergence activity against a broad spectrum of grass weed species for worldwide selective use in both wheat and barley. RESULTS Factors influencing activity and tolerance to pinoxaden were in part linked to distinct structural parts of the active ingredient. Three complementary contributions that decisively impact upon the herbicidal potency against grasses were identified: a preferred 2,6-diethyl-4-methyl aromatic substitution pattern, a dione area suitable for proherbicide formation and beneficial adjuvant effects. The uptake and translocation pattern of pinoxaden when coapplied with its tailored adjuvant were analysed by autoradiography, indicating extensive and rapid penetration, followed by effective distribution throughout the plant. Crop injury reduction on incorporation of the [1,4,5]oxadiazepane ring into the aryldione template was reinforced with safener technology. Comparative studies on the behaviour of pinoxaden applied either alone or in combination with the safener cloquintocet-mexyl demonstrated that addition of the safener resulted in significant enhancement of metabolic degradation in wheat and barley, providing excellent crop tolerance and a substantial selectivity margin without adverse effects on weed control. CONCLUSION The biological potential of pinoxaden and its active principle pinoxaden dione in terms of grass weed control and tolerance in cereals was fully exploited by inclusion of the safener cloquintocet-mexyl in the formulation in combination with a specific and tailor-made tank-mix adjuvant based on methylated rape seed oil.
Archive | 1991
Peter Maienfisch; Thomas Rapold; Henry Szczepanski
Archive | 2000
Thomas Maetzke; René Mutti; Henry Szczepanski
Archive | 1996
Thomas Göbel; Ottmar Franz Hüter; Peter Maienfisch; Anthony Cornelius O'sulllivan; Thomas Pitterna; Thomas Rapold; Marcel Senn; Henry Szczepanski
Archive | 1994
Manfred Böger; Peter Maienfisch; Thomas Pitterna; Henry Szczepanski
Archive | 2001
Martin Zeller; Clemens Lamberth; Henry Szczepanski; Alain De Mesmaeker
Archive | 2009
Thomas Pitterna; Henry Szczepanski; Peter Mainenfisch; Ottmar Franz Hüter; Thomas Rapold; Marcel Senn; Thomas Göbel; Anthony Cornelius O'sullivan
Archive | 2003
Martin Zeller; Clemens Lamberth; Henry Szczepanski; Alain De Mesmaeker
Archive | 2005
Martin Zeller; Clemens Lamberth; Henry Szczepanski; Alain De Mesmaeker
Archive | 2001
Martin Zeller; Clemens Lamberth; Henry Szczepanski; Alain De Mesmaeker